GlobalData on MSN16h
HMRI and Novartis Australia sign MoU to expedite medical researchThe MoU combines HMRI and the University of Newcastle's research expertise with Novartis' medical solutions leadership. It ...
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an ...
On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback